Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NNFA DHEA campaign

This article was originally published in The Tan Sheet

Executive Summary

The National Nutritional Foods Association is planning a "grassroots" campaign to oppose a new bill that would reclassify dehydroepiandrosterone (DHEA) as an anabolic steroid. The proposed legislation would add a "safe and effective" supplement to the list of controlled substances, "effectively banning it," the trade group maintains. Sens. Charles Grassley (R-Iowa), John McCain (R-Ariz.) and George Allen (R-Va.) introduced the bill May 26 (1"The Tan Sheet" June 6, 2005, p. 11)...

You may also be interested in...

DHEA Debate Returns To Fore: Anabolic Steroid Status Sought In Grassley Bill

A new bill sponsored by Sen. Charles Grassley (R-Iowa) would regulate dehydroepiandrosterone (DHEA) as an anabolic steroid under the Controlled Substances Act

Japan Regulators Kept On Track Despite Pandemic

While it was not as affected as some other countries, Japan still had the pandemic to deal with and regulators responded while managing to keep up regular product review work, including several world-first approvals. Coronavirus vaccine roll-outs and the first general annual reimbursement price cut are on the cards for this year. 

QUOTED. 21 January 2021. Larry Biegelsen.

The recently US FDA-cleared Velys robotic-assisted system from DePuy Synthes has distinct features. It also has a small footprint that makes it well-suited for ambulatory surgery centers. See what Larry Biegelsen, an analyst with Wells Fargo, said about it here.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts